LRMRLarimar Therapeutics, Inc.

Nasdaq larimartx.com


$ 7.38 $ -0.37 (-4.77 %)    

Friday, 10-May-2024 10:59:57 EDT
QQQ $ 441.39 $ -1.53 (-0.35 %)
DIA $ 394.85 $ -0.42 (-0.11 %)
SPY $ 520.57 $ -0.95 (-0.18 %)
TLT $ 90.08 $ -0.23 (-0.25 %)
GLD $ 218.32 $ -1.30 (-0.59 %)
$ 7.86
$ 7.75
$ 0.00 x 0
$ 0.00 x 0
$ 7.35 - $ 7.75
$ 2.18 - $ 13.68
190,605
na
420.93M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-14-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-14-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-25-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-04-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-09-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-10-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-13-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-14-2015 03-31-2015 10-Q
38 03-25-2015 12-31-2014 10-K
39 11-13-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 larimar-therapeutics-q1-2024-gaap-eps-027-beats-028-estimate

Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of ...

 leerink-partners-initiates-coverage-on-larimar-therapeutics-with-outperform-rating-announces-price-target-of-25

Leerink Partners analyst Joori Park initiates coverage on Larimar Therapeutics (NASDAQ:LRMR) with a Outperform rating and an...

 jmp-securities-reiterates-market-outperform-on-larimar-therapeutics-maintains-25-price-target

JMP Securities analyst Jonathan Wolleben reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Market Outperform and maintain...

 larimar-therapeutics-q4-eps-030-misses-025-estimate-cash-position-868m

Larimar Therapeutics (NASDAQ: LRMR) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate ...

 jmp-securities-reiterates-market-outperform-on-larimar-therapeutics-maintains-25-price-target

JMP Securities analyst Jonathan Wolleben reiterates Larimar Therapeutics (NASDAQ:LRMR) with a Market Outperform and maintain...

 larimar-therapeutics-announces-the-dosing-of-the-first-patient-in-long-term-open-label-extension-study-for-nomlabofusp-in-patients-with-friedreichs-ataxia

Study will inform on long-term safety profile and tissue frataxin levels OLE initiated with 25 mg daily subcutaneous injecti...

 over-37m-bet-on-this-healthcare-stock-check-out-these-4-stocks-insiders-are-buying

Although U.S. stocks closed lower on Friday, there were a few notable insider trades.

 cisco-issues-weak-outlook-joins-fastly-herbalife-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures trading higher by around 70 points on Thursday.

 why-sony-shares-are-trading-lower-by-around-6-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financi...

 charles-river-laboratories-international-posts-upbeat-results-joins-robinhood-zillow-tower-semiconductor-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.

 larimar-therapeutics-announces-proposed-underwritten-public-offering-no-size-or-amount-disclosed

Larimar Therapeutics, Inc. ("Larimar") (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing trea...

 why-ipg-photonics-shares-are-trading-lower-by-around-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed four...

 ecolab-posts-strong-results-joins-masonite-international-impinj-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION